Spotlight
Clinical Role
Clinical
Supplement Spotlight
CE
Subscribe
Richard H. Pham, PharmD
Articles
Tara L. Purvis, PharmD, BCPP;Leigh Anne Nelson, PharmD, BCPP;Ellie S. R. Elliott, PharmD, BCPP;Robin N. Hieber, PharmD, BCPP;Yifei Liu, BS Pharm, PhD;Richard H. Pham, PharmD;Stuart Munro, MD;an
October 5th 2011Adherence to risperidone long-acting injection (RLAI) therapy in the outpatient setting was poor. Degree of discharge planning from inpatient hospitalization was not associated with RLAI adherence.
Read More
Latest Updated Articles
Published: October 23rd 2024 | Updated: October 24th 2024
What to Know About E Coli Outbreak Linked to McDonald’s Quarter Pounders
Published: January 18th 2016 | Updated: October 18th 2024
10 Pharmacy Quotes That Will Make You Rethink the Profession
Published: September 22nd 2015 | Updated: October 14th 2024
Gabapentin Differs From Pregabalin in Several Key Ways
Published: August 30th 2024 | Updated: November 22nd 2024
Congress Requests Corrections to Testimony From Three Largest Pharmacy Benefit Manager Executives Following FTC Report
Published: October 8th 2024 | Updated: November 22nd 2024
What Drug Rates Are Reported in Price Transparency Data?
Published: October 7th 2024 | Updated: November 22nd 2024
What Went Wrong: How Formularies, Contracts, and Rebates Created a Headwind for Biosimilars
